You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 120 No. 9, September 2002 TABLE OF CONTENTS
  Archives
  •  Online Features
  Correspondence
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Intravenous Recombinant Tissue-Type Plasminogen Activator Thrombolysis in Treatment of Central Retinal Artery Occlusion

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The natural history of untreated central retinal artery occlusion (CRAO) implies a high risk of permanent blindness.1-2 The favorable outcome of intravenous thrombolysis in stroke treatment prompted us to develop an Institutional Review Board–approved pilot study of acute CRAO treatment with intravenous thrombolysis. We describe our experience with 12 patients with acute CRAO who were treated with recombinant tissue-type plasminogen activator (rtPA), following the protocol used in the national acute stroke trial.3

Patients and Methods

From October 1998 through October 2000, patients who were diagnosed with acute CRAO or ophthalmic artery occlusion, and who experienced visual loss within the preceding 24 hours, were referred as candidates for thrombolysis. A protocol ophthalmologist (C.R., Parashos Lagouros, MD, or Martha Willi, MD) confirmed the diagnosis of CRAO. Snellen chart visual acuity and intraocular pressure were tested. If intraocular pressure was more than 12 mm Hg, an ophthalmologist (C.R., Parashos Lagouros, or Martha Willi, MD) performed an . . . [Full Text of this Article]

Results

Comment

Corresponding author and reprints: Jorge C. Kattah, MD, Department of Neurology, University of Illinois College of Medicine at Peoria, OSF Saint Francis Medical Center, 530 NE Glen Oak Ave, Peoria, IL 61637 (e-mail: kattahj@uic.edu).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Intra-arterial thrombolysis for central retinal artery occlusion
Hayreh
Br. J. Ophthalmol. 2008;92:585-587.
FULL TEXT  

Intra-arterial thrombolysis for central retinal artery occlusion: a systematic review
Noble et al.
Br. J. Ophthalmol. 2008;92:588-593.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.